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Abstract 
Background: Prostate cancer (PCa) is an important health problem in the aging male population in the world. It 
is the third most common cancer in the world. Despite of its importance, relatively little is known about its 
etiology. Sexually transmitted infections (STI) and urogenital pathogens such as Mycoplasma and Ureaplasma, 
have been proposed as a risk factor for prostate cancer development. This study aimed at detecting the 
prevalence of Ureaplasma urealyticum (U. urealyticum) and Mycoplasma genitalium (M. genitalium) in PCa 
and the controls group with benign prostate hyperplasia (BPH) in Shohada hospital. 
Materials and Methods: A total of 124 paraffin-embedded prostate tissues (62 PCa patients and 62 controls 
with BPH) were included in this study. The subjects'specimens were investigated by the polymerase chain 
reaction method for the presence of U. urealyticum and M. genitalium DNA. 
Results: U. urealyticum was detected by standard PCR in 1.61% of the 62 PCa patients and there was no 
DNA U. urealyticum in the 62 controls with BPH. No M. genitalium was detected by standard PCR in the 
prostates of 124 paraffin-embedded prostate tissues. 
Conclusion: According to our results, there is no association between M. genitalium and U.urealyticum with 
PCa. We recommend further studies using a large sample to determine role of Ureaplasma and Mycoplasma in 
PCa because understanding the role of infectious agents on PCa might be useful for developing new therapeutic 
approaches and prevention of PCa. 
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Nowadays prostate cancer (PCa) is one of the most 
important health challenge in the aging male 
population and the third most common cancer in the 
world
1,2
. There is a direct relation between incidence 
and age in this disease (about 65 years or more)
3
. The 
higher rates of PCa are seen in Western countries, 
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North America and in some African regions. The 
lowest incidence is seen in Asian countries. 
However, with aging populations and using prostate 
specific antigen (PSA) screening, the incidence of 
prostate cancer in the Asian countries has risen in the 
past decade
4
. The incidence of PCa is much lower in 
Iran than developed countries. In the recent studies, 
the incidence of PCa in Iran was approximately 
3.5%
5,6
. Although the rate of PCa is very common in 
the world, relatively little is known about its causes
7
. 
It has been well established worldwide that at least 
15-20% of all cancers are associated with infections, 
as etiologic agent, such as the association between 
Helicobacter pylori infection with gastric cancer
8-11
. 
Recent studies proposed that chronic infections may 
develop PCa. Infections such as urinary tract 
infections (UTIs), sexually transmitted infections 
(STIs) caused by mycoplasam and Ureaplasma were 
shown to be associated with PCa as well as the 
genitourinary tract can be colonized with 
Ureaplasma urealyticum (U. urealyticum) and 
Mycoplasam genitalium (M. genitalium)
12-16
.  
Mycoplasma and Ureaplasma are small, without cell 
wall and with sterols in membrane bacteria
17
. Today, 
it has been demonstrated that chronic infection with 




In the present study, we examined the prevalence of 
M. genitalium and U. urealyticum in PCa and the 
control group with benign prostate hyperplasia 
(BPH) using standard Polymerase Chain Reaction 
method (PCR) in a population of men in Shohada 
hospital, Tehran, Iran. 
Methods 
This was a descriptive survey of 62 PCa and 62 non 
PCa pathological specimens collected from patients 
aged between 50-89, referred to Shohada hospital, 
Tehran-Iran from 2007-2012. Demographic data, 
including the histological type of cancer, gleason 
score (GS), prostatic intraepithelial neoplasia (PIN) 
and PSA were recorded. Then formalin-fixed and 
paraffin-embedded tissue sections of open 
prostatectomy, core needle biopsy and trans urethral 
resection of the prostate (TURP) samples were 
examined from patients with PCa and from patients 
with BPH. A single pathologist experienced in 
urogenital pathology performed microscopic 
evaluation of the microscopic slides to determine the 
cancerous and non-cancerous tissue differentiation. 
The best paraffin-embedded block containing 
cancerous tissue of the patients with prostate cancer 
was selected for examination. Samples were 
transported to Department of Microbiology, Medical 
School, Shahid Beheshti University of Medical 
Sciences for further analysis. 
DNA was extracted from formalin-fixed and paraffin-
embedded tissue blocks by G-spin TM Total DNA 
Extraction Kit (iNtRON Biotechnology Co., Korea). 
First, the paraffin blocks were sliced into thin pieces 
using a sterile razor blade and were placed in a 1.5 ml 
tube (not more than 25 mg). According to the 
manufacturerʼs instructions, xylene was used for the 
removal of paraffin and then the bacterial DNA was 
extracted from tissue. DNA concentration and purity 
was measured by spectrophotometry. Mean and 
standard error of the mean were calculated and 
analyzed for significance in different. The extracted 
DNA was stored at -20˚C. 
The PCR assay for detection of M. genitalium and U. 
urealyticum performed by mycoplasma genitalium 
PCR Detection Kit (Pars tous Co., Iran) and 
Ureaplasma urealyticum PCR Detection Kit (Pars tous 
Co., Iran), respectively. Primers within the M. 
genitalium PCR Mix and U. urealyticum PCR Mix 
was specific for the conserved 16srRNA coding region 
in the Mycoplasma and Ureaplasma genome. 
The PCR reaction mixture contained 14.6 μl of 
M.genitalium PCR mix and U. urealyticum PCR mix 
(for detection of M. genitalium and U. urealyticum, 
respectively), 0.4 μl of HS-Taq DNA polymerase and 
5 μl of DNA template was used for adjusting to a final 
volume of 20 μl. For negative and positive controls 
used 5 μl of PCR grade water and 5 μl positive 
controls, respectively. 
PCR mixtures were cycled under the following 
thermal conditions: Initial denaturation 94˚C for 10 
min, 40 cycles in denaturation 94˚C for 30 sec, 
annealing 56˚C for 30 sec, extension 67˚C for 30 sec 
and final extension 72˚C for 5 min. 
The PCR products were analyzed on 2% agarose gel 
electrophoresis and the gel was stained with ethidium 
bromide (0.5 μg/ml) and viewed by UV 
transilluminator. The presence of 255 base paires (bp) 
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and 370 bp fragments were positive for M. 
genitalium and U. urealyticum respectively. 
Demographic data were analyzed using Statistical 
Package for Social Sciences (SPSS) software 
(version 16). 
Results 
The mean age of PCa patients was 67.8±7.9 years 
(range50-86 years) and in BPH patients 68±9.1 years 
(range 40-89 years). The characteristics of the study 
population and GS information (grade of PCa) are 
summarized in Table1.  
The genomic DNA extraction results using G-spin 
TM Total DNA Extraction Kit was shown high 
quality and quantity of DNA collected from all 
samples (Normal range of purity of DNA=1.9±0.2 
and normal range of A260= 0.1-1). 
To detect M. genitalium and U. urealitycum in PCa 
patients and controls with BPH, we used PCR assay 
for each one separately. The results of PCR showed 
the U. urealitycum was positive in 1 (1.61%) of the 
62 PCa patients (Figure 1) but the U. urealitycum 
was not detected in control samples. None of the 124 
prostate samples were positive for the M. genitalium 
(Figure 2) and no significant differences were found 
between the presence of these bacteria and PCa [p 
value >0.001; OR=1; 95% CI (0.985-1.049)]. PSA 
value was 60 ng/ml in the patient who was 
Ureaplasma DNA positive. He was 50 years old and 
he had poorly differentiated tumor (Gleason 9). 
Discussion 
Since the early 1950s, when sexually transmitted 
infections (STIs) were first proposed as a possible PCa 
risk factor
23
, numerous epidemiologic studies have 
been examined. There is compelling evidence that 
urogenital infections are associated with PCa
12, 13
. 
However, in several studies did not find an association 
between PCa and any specific bacterial infections
24,25
. 
Therefore, the evidence is not clear-cut and require 
more subtle investigation. In this study, we 
investigated the possible role of M. genitalium and U. 
ueralyticum as risk factors in the PCa using PCR 
method. M. genitalium and U. urealyticum has been 
identified as one of the main causes of non-gonococcal 
urethritis in the world
26,27
. Our study showed that the 
incidence of M. genitalium and U. urealyticum 
positively was 0.0 % and 1.6 % in the case group with  
Table 1: The study population characteristics. 
 
Characteristic PCa BPH 
Total number of patients 62 62 
























































PIN 11 (17.7%) - 
PCa Prostate cancer, BPH Benign prostate hyperplasia, TURP Transurethral resection of the prostate, PSA Prostate specific 
antigen, PIN Prostatic intraepithelial neoplasia 
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PCa, respectively. No M. genitalium and U. 
urealyticum were detected in the control group with 
BPH. Until now, as far as we know, there have been 
no studies in Iran about the incidence of bacterial 
infection in PCa, but in several studies have been 
examined detection of M. genitalium and U. 
urealyticum in men in other diseases. Salari and 
Karimi (2003) reported that the prevalence of M. 
genitalium and U. urealyticum in urethral swab 
samples from men with non-gonococcal urethritis in 
Tehran, Iran was 19.2 % and 7.2%, respectively
28
. 
Yeganeh et al. (2013) have been shown the 
prevalence of M. genitalium in Urine specimens was 
revealed to be 12% and 2% symptomatic and 
asymptomatic men, respectively
29
. The prevalence of 
U. urealyticum was 12% in semen specimens of 
infertile men and 3 % in healthy men
30
. 
Differences in the prevalence of Mycoplasma and 
Ureaplasma in our study with other studies in Iran 
could be related to the type of diseases and samples. 
In a similar study, Erturhan et al. reported that  
mycoplasma infections play a role in the 
etiopathogenesis of the PCa. The Mycoplasma spp. 
DNA was found to be positive in 35.4% patients in 
PCa and there was no mycoplasma DNA in the 
control group with BPH
15
. The racial, geographical 
and cultural differences could be the reason for this 
difference. Also the difference in results could be due 
to the type of sampling. In his study, all samples 
were collected using the TURP procedure. In this 
method, a piece of the prostate is removed through 
the urethra. Because numerous species of 
Mycoplasma can be present as normal flora in the 
urethra, so there is a possibility of contamination of 
the prostate samples during the sampling by TURP 
procedure. But more than 50% of the cancer subjects 
in our study was the prostatectomy specimens. Similar 
to our study, in other studies that prostate cancer 
tissues collected by prostatectomy have not detected 
the presence of Mycoplasma spp
11,31
. 
Barykova et al. detected M. hominis infection in 
15.2% and 37.4% of PCa patients using PCR and real-
time PCR, respectively. While, M. genitalium and U. 
ueralyticum were only detected in 5.6% and 0.8% of 
the patients using PCR, respectively. None of the three 
species were detected in control samples. Therefore, 
they have been suggested that M.hominis may be 
involved in PCa development
14
. In his study, M. 
hominis DNA was detected in transrectal prostate 
biopsy samples. Although most commonly known as a 
commensal organism in the human genitourinary tract, 
Mycoplasma hominis is also present in the human 
rectum
32
. Whereas, M. hominis have not detected in 




Recently, three case-control study based on serology 
(such as ELISA and immunofluorescence), has 
investigated the relationship between mycoplasma and 
prostate cancer. As they has been shown that 
antibodies against M. hyorhinis, M. hominis and U. 






Figure 1. Results of standard PCR assay for detection of M. 
genitalium DNA (16S rRNA gene). (1-5): DNA from prostate 
tissue of patients, 6(M): 50 bp ladder, (7) Psitive control, (8) 




Figure 2. Results of standard PCR assay for detection of U. 
urealyticum DNA (16S rRNA gene). (1): negative control, 2(M): 
50 bp ladder, (3): positive control, (4): U. urealyticum DNA 
negative from prostate tissue of patient, (5) U. urealyticum DNA 
positive from prostate tissue of patient. 
U. urealyticum (370 pb fragment) 
M. genitalium (255 bp fragment). 
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According to our results, there is no association 
between M. genitalium and U. urealyticum with PCa 
using PCR. A possible explanation for this result is 
that the detection infectious agent in clinical tissues 
by using PCR techniques is difficult, because in these 
techniques only a small fraction of the tissue is 
examined. Knowing that inflammation, and probably 
also bacteria and viruses, are unevenly distributed in 
the prostate, the risk of missing focally infected areas 
is high. On the other hand, this difference may be due 
to the fact the tissue samples were formalin-fixed and 
paraffin-embedded and bacterial DNA may be 
damaged due to the long storage samples. Also, the 
sample size was small and the incidence of 
Mycoplasma infections is much lower in Iran than 
other countries with different cultures. So, we 
recommend further experimental studies using a 
large sample to determine the role of Ureaplasma 
and Mycoplasma in PCa because understanding the 
role of infectious agents on PCa might be useful for 
developing new therapeutic approaches and 
prevention of PCa. 
Conclusion 
In this study, we conclude that the association 
between PCa and infections caused by Mycoplasma 
and Ureaplasma is not supported. As regards role of 
mycoplasma and Ureaplasma in the genesis of PCa is 
not conclusively proven yet, further studies are 
needed. 
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